Long-term outlook and what the research shows Retatrutide is still in clinical development, with Phase 3 trials ongoing
A class of drugs called GLP-1 agonists, which includes Ozempic (semaglutide), has been used to treat type 2 diabetes for over a decade
This indicates that patients may still experience the appetite regulation benefits of GLP-1s, even at lower doses, and the effects may be more gradual and gentler, which could be beneficial for long-term adherence
Our Score: 4/5 Before you sign up, see how Shed performs across these five categories
Across the primary maintenance arms, only 5 participants discontinued treatment due to adverse events during the monthly dosing phase
No added stimulants: Formulated without stimulants, gentle on digestion and suitable for prolonged use within a balanced diet